Sandoz Transderm Scop 1.5mg 24-Patch Recall: Defective Delivery System Risk
Sandoz recalls Transderm Scop 1.5mg 24-patch multi-packs due to defective delivery system that may alter scopolamine release. Affected units have specific NDC and lot numbers. Contact Sandoz for details.
Lower-risk recall
Defective Delivery System; reports of damaged product that may alter the predicted release of scopolamine following transdermal application.
Contact the company
What happened, in plain English
Sandoz has recalled Transderm Scop 1.5mg transdermal patches (24-pack) because the delivery system might release scopolamine incorrectly. This could lead to improper medication levels if used as intended. Read more at govinfonow.com/recall/42469-sandoz-transderm-scop-1-5mg-24-patch-recall-defective-delivery.
Source Summary by GovInfoNow · govinfonow.com/recall/42469-sandoz-transderm-scop-1-5mg-24-patch-recall-defective-delivery · Updated October 9, 2026 · FDA enforcement record: FDA #D-0133-2017
Cite this page
“Sandoz Transderm Scop 1.5mg 24-Patch Recall: Defective Delivery System Risk.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42469-sandoz-transderm-scop-1-5mg-24-patch-recall-defective-delivery. Based on FDA recall #D-0133-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0133-2017%22&limit=1).
Why it’s dangerous
The delivery system in the patches may malfunction, causing scopolamine to be released at an incorrect rate. This could result in either too little or too much medication being absorbed through the skin.
Who’s affected
People with prescriptions for Transderm Scop 1.5mg 24-patch multi-packs from the listed lot numbers and NDCs are affected. Those using the product for motion sickness or post-surgery recovery are most at risk.
How to tell if you have this one
Check for NDC numbers 10019-553-02 or 10019-553-88, and lot numbers like FV5908, FX1520, GB4910, GC4210, GE1927, GF7017, or GH8065. The product expires by specific dates listed in the recall.
- Brand
Sandoz- Category
Drug
What to do — step by step
Check Product Details
Identify the NDC number and lot number on the product packaging to confirm if it is affected.
Where it went and when
Where it was distributed
Distributed in Tennessee.
FDA distribution: “TN” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Tennessee.
Recall timeline
FDA terminated this recall 9 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
What is the expiry date for the recalled product?
The recalled product has specific expiry dates: 06/2018, 09/2018, 12/2018, 01/2019, and 02/2019 depending on the lot number.
Similar recalls
Other Sandoz recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0133-2017 (August 24, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0133-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.